PMID- 37957180 OWN - NLM STAT- MEDLINE DCOM- 20231115 LR - 20231116 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 13 IP - 1 DP - 2023 Nov 13 TI - Human leukocyte antigen-DQ risk heterodimeric haplotypes of left ventricular dysfunction in cardiac sarcoidosis: an autoimmune view of its role. PG - 19767 LID - 10.1038/s41598-023-46915-1 [doi] LID - 19767 AB - Cardiac sarcoidosis (CS) is the scarring of heart muscles by autoimmunity, leading to heart abnormalities and patients with sarcoidosis with cardiac involvements have poor prognoses. Due to the small number of patients, it is difficult to stratify all patients of CS by human leukocyte antigen (HLA) analysis. We focused on the structure of antigen-recognizing pockets in heterodimeric HLA-class II, in addition to DNA sequences, and extracted high-affinity combinations of antigenic epitopes from candidate autoantigen proteins and HLA. Four HLA heterodimer-haplotypes (DQA1*05:03/05:05/05:06/05:08-DQB1*03:01) were identified in 10 of 68 cases. Nine of the 10 patients had low left ventricular ejection fraction (< 50%). Fourteen amino-acid sequences constituting four HLA anchor pockets encoded by the HLA haplotypes were all common, suggesting DQA1*05:0X-DQB1*03:01 exhibit one group of heterodimeric haplotypes. The heterodimeric haplotypes recognized eight epitopes from different proteins. Assuming that autoimmune mechanisms might be activated by molecular mimicry, we searched for bacterial species having peptide sequences homologous to the eight epitopes. Within the peptide epitopes form the SLC25A4 and DSG2, high-homology sequences were found in Cutibacterium acnes and Mycobacterium tuberculosis, respectively. In this study, we detected the risk heterodimeric haplotypes of ventricular dysfunction in CS by searching for high-affinity HLA-class II and antigenic epitopes from candidate cardiac proteins. CI - (c) 2023. The Author(s). FAU - Yamamoto, Hironori AU - Yamamoto H AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. FAU - Miyashita, Yohei AU - Miyashita Y AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. miyashita.yohei@ncvc.go.jp. AD - Department of Legal Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan. miyashita.yohei@ncvc.go.jp. FAU - Minamiguchi, Hitoshi AU - Minamiguchi H AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. FAU - Hosomichi, Kazuyoshi AU - Hosomichi K AD - Laboratory of Computational Genomics, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan. FAU - Yoshida, Shohei AU - Yoshida S AD - Department of Cardiovascular Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa, 920-8641, Japan. FAU - Kioka, Hidetaka AU - Kioka H AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. FAU - Shinomiya, Haruki AU - Shinomiya H AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. FAU - Nagata, Haruno AU - Nagata H AD - Department of Cardiovascular Medicine, University of the Ryukyus Graduate School of Medicine, Nakagami, Okinawa, 903-0215, Japan. FAU - Onoue, Kenji AU - Onoue K AD - Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Nara, 634-8522, Japan. FAU - Kawasaki, Masato AU - Kawasaki M AD - Department of Cardiology, Osaka General Medical Center, Osaka, Osaka, 558-8558, Japan. FAU - Kuramoto, Yuki AU - Kuramoto Y AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. FAU - Nomura, Akihiro AU - Nomura A AD - Innovative Research Center, Kanazawa University School of Medicine, Kanazawa, Ishikawa, 920-8641, Japan. FAU - Toma, Yuichiro AU - Toma Y AD - Department of Cardiovascular Medicine, University of the Ryukyus Graduate School of Medicine, Nakagami, Okinawa, 903-0215, Japan. FAU - Watanabe, Tetsuya AU - Watanabe T AD - Department of Cardiology, Osaka General Medical Center, Osaka, Osaka, 558-8558, Japan. FAU - Yamada, Takahisa AU - Yamada T AD - Department of Cardiology, Osaka General Medical Center, Osaka, Osaka, 558-8558, Japan. FAU - Ishihara, Yasuki AU - Ishihara Y AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. AD - The 1st Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan. FAU - Nagata, Miho AU - Nagata M AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. AD - Department of Medical Ethics and Medical Genetics, Kyoto University Graduate School of Medicine, Kyoto, Kyoto, 606-8501, Japan. FAU - Kato, Hisakazu AU - Kato H AD - Department of Medical Biochemistry, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan. FAU - Hakui, Hideyuki AU - Hakui H AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. FAU - Saito, Yoshihiko AU - Saito Y AD - Department of Cardiovascular Medicine, Nara Prefecture Seiwa Medical Center, Nara, Nara, 636-0802, Japan. FAU - Asano, Yoshihiro AU - Asano Y AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. asano.yoshihiro@ncvc.go.jp. AD - Department of Genomic Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, 564-8565, Japan. asano.yoshihiro@ncvc.go.jp. FAU - Sakata, Yasushi AU - Sakata Y AD - Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20231113 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (HLA-DQ alpha-Chains) RN - 0 (HLA-DQ beta-Chains) RN - 0 (HLA-DQ Antigens) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Epitopes) RN - 0 (Peptides) RN - 0 (HLA-DRB1 Chains) SB - IM MH - Humans MH - Haplotypes MH - Stroke Volume MH - HLA-DQ alpha-Chains/genetics MH - HLA-DQ beta-Chains/genetics MH - Ventricular Function, Left MH - HLA-DQ Antigens/genetics MH - Histocompatibility Antigens Class I/genetics MH - *Sarcoidosis/genetics MH - Epitopes MH - *Ventricular Dysfunction, Left/genetics MH - Peptides/genetics MH - HLA-DRB1 Chains/genetics MH - Gene Frequency MH - Alleles MH - Genetic Predisposition to Disease PMC - PMC10643531 COIS- The authors declare no competing interests. EDAT- 2023/11/14 00:42 MHDA- 2023/11/15 06:43 PMCR- 2023/11/13 CRDT- 2023/11/13 23:20 PHST- 2022/12/13 00:00 [received] PHST- 2023/11/07 00:00 [accepted] PHST- 2023/11/15 06:43 [medline] PHST- 2023/11/14 00:42 [pubmed] PHST- 2023/11/13 23:20 [entrez] PHST- 2023/11/13 00:00 [pmc-release] AID - 10.1038/s41598-023-46915-1 [pii] AID - 46915 [pii] AID - 10.1038/s41598-023-46915-1 [doi] PST - epublish SO - Sci Rep. 2023 Nov 13;13(1):19767. doi: 10.1038/s41598-023-46915-1.